# Nuclear transfer : progress and quandaries

Xuemei Li, Ziyi Li, Alice Jouneau, Qi Zhou, Jean Paul J. P. Renard

► To cite this version:

Xuemei Li, Ziyi Li, Alice Jouneau, Qi Zhou, Jean Paul J. P. Renard. Nuclear transfer: progress and quandaries. Reproductive Biology and Endocrinology, 2003, 1 (84), 6 p. 10.1186/1477-7827-1-84. hal-02677996

HAL Id: hal-02677996

https://hal.inrae.fr/hal-02677996

Submitted on 31 May 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Review

Open Access

**Nuclear transfer: Progress and quandaries**

Xuemei Li¹, Ziyi Li², Alice Jouneau³, Qi Zhou*¹,³ and Jean-Paul Renard³

Address: ¹Institute of Zoology, Chinese Academy of Science, Beijing 100080; PR China, ²Department of Anatomy & Cell Biology, College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA and ³UMR Biologie du Développement et Reproduction, Bât 440, INRA, 78350, Jouy-en-Josas, France

Email: Xuemei Li - lixm@panda.ioz.ac.cn; Ziyi Li - ziyi-li@uiowa.edu; Alice Jouneau - jouneau@jouy.inra.fr; Qi Zhou* - qzhou@panda.ioz.ac.cn; Jean-Paul Renard - renard@jouy.inra.fr

Published: 07 November 2003

Received: 14 July 2003

Reproductive Biology and Endocrinology 2003, 1:84

Accepted: 07 November 2003

This article is available from: http://www.rbej.com/content/1/1/84

© 2003 Li et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

**Abstract**

Cloning mammals by nuclear transfer is a powerful technique that is quickly advancing the development of genetically defined animal models. However, the overall efficiency of nuclear transfer is still very low and several hurdles remain before the power of this technique will be fully harnessed. Among these hurdles include an incomplete understanding of biologic processes that control epigenetic reprogramming of the donor genome following nuclear transfer. Incomplete epigenetic reprogramming is considered the major cause of the developmental failure of cloned embryos and is frequently associated with the disregulation of specific genes. At present, little is known about the developmental mechanism of reconstructed embryos. Therefore, screening strategies to design nuclear transfer protocols that will mimic the epigenetic remodeling occurring in normal embryos and identifying molecular parameters that can assess the developmental potential of pre-implantation embryos are becoming increasingly important. A crucial need at present is to understand the molecular events required for efficient reprogramming of donor genomes after nuclear transfer. This knowledge will help to identify the molecular basis of developmental defects seen in cloned embryos and provide methods for circumventing such problems associated with cloning the future application of this technology.

**Introduction**

Nuclear transfer (NT) is a powerful technique for exploring functional changes in the genome during differentiation. Its application is currently being expanded to generate genetically modified animals. Theoretically, using NT technology can establish a population with genetic characteristics from one genetically modified or genetically specific individual. Although somatic nuclear transfer has been successfully achieved in various species, its efficiency has been very low until recently. The inefficiency lies in many areas, such as in the donor cell types, cell cycle stages, genetic background of donor cells and recipient oocytes, nuclear transfer procedure, and culture

environments [1-3]. Because little is known about the developmental mechanisms of reconstructed embryos, it is difficult to optimize the conditions for increasing their efficiency. In this article, we will summarize new advances in NT and the quandaries that have yet to be resolved.

**Progress in Nuclear Transfer**

The factors involved in the success of NT are very complex. Although many protocols have been modified and utilized in NT processes, some events continue to remain ill-defined. NT in theory attempts to re-establish the "developmental program" of a somatic donor genome to a primordial "ES-cell like" state. Regardless of the inefficiencies

<footnote>* Corresponding author</footnote>
of this process currently, morphologically normal living animals have been produced in 10 species during the past few years including sheep [4], mouse [5], cow [6], goat [7], pig [8], rabbit [9], cat [10], mule [11], horse [12], and rat [13]

In all successful NT cloning experiments, the unfertilized cytoplasm of the oocyte was confirmed to be the capable recipient, suggesting that certain factors in unfertilized oocyte are essential for reprogramming the donor genome. Such factors are lost or insufficient following fertilization of the oocyte. The events in the first several cell cycles of cloned embryos, therefore, are critical to the establishment of fully reprogrammed genomes. Gastrulation is a vital stage for cloned embryos. A high rate of abortion during gestation has been observed in cloning experiments performed on different species [5,16,17]. These late miscarriages are also frequently associated with abnormal development of the placenta [18]. Cloned embryos and offspring also often show many abnormalities, including circulatory distress, placenta edema, hydrallantois, and chronic pulmonary hypertension. The surviving offspring also have large placentas and increased birth weights, and they suffer a high incidence of death [14,15].

The low efficiency and abnormal development of cloned animals are mainly due to incomplete reprogramming and abnormal gene expression. The expression of several important genes has been assessed in cloned embryos [19,20]. In a study in which global gene expression was analyzed by microarray in NT embryos derived from stem cells and somatic cells, 4% of more than 10,000 genes differed in expression from the controls [21].

## Quandaries in Nuclear Transfer

Although some achievements have been made in the field of nuclear transfer, many quandaries still persist. One example is the aberrant reprogramming observed in physically normal cloned adults.

## Aberrant Reprogramming and Physically Normal Cloned Adults

Considering the frequency of abnormal gene expression, it could be considered surprising that physically, functionally, and histologically normal cloned adults have been produced in several species. When a fertile cloned animal is delivered, the donor cells should be reprogrammed into a state compatible with embryonic development. However, most cloned embryos have been observed to fail to develop to term, and some of the surviving cloned animals have shown abnormalities. The major cause may reside in faulty or incomplete epigenetic reprogramming of the donor nucleus, which affects the gene expression needed for every developmental stage of cloned embryos

and offspring. Most cloned embryos lose their developmental abilities during pre-implantation and gastrulation. Moreover, the surviving adults often show abnormalities.

To better understand the issues controlling incomplete epigenetic reprogramming, we have compared the long-term viability of mice derived from ES nuclei and somatic nuclei. Reconstructed embryos were transferred into foster mothers, and caesarean sections were performed at day 19 of gestation. The combined weight of placentas for all cloned pups obtained was approximately double the weight of the control. From the standpoint of live birth cloned pups, more than half of the pups suffered from respiratory failure and general weakness and died only a few hours after delivery. The weight curves of NT mice that did survive were followed for 12 to 19 months and were similar to those of the controls. This study also resulted in two infertile cloned mice out of 9, both of which could mate and give vaginal plugs normally; however, histology of the testicle of one of them showed a reduced number of germinal cells with no spermatozoa detectable in the epididymis, and surprisingly, spermatozoa were found in the epididymis of the other male, although it was proven not to be able to produce fertilised zygotes after natural mating. Some mice died after one year, suffering from multiple necrotic wounds. In order to obtain physical parameters, we sacrificed some cloned mice at different ages (1, 8, and 19 months old) and compared them to control animals of the same ages. Blood count and formula were determined, and several organs (the lung, liver, spleen, testis, and kidney) were processed for histology. No marked differences could be detected between normal and cloned animals. Of the seven NT animals, only two were overweight, compared to one out of five for the controls. Our data, together with the fact that one of our first NT mice obtained from somatic nuclei (cumulus) was still physiologically normal before mercy killing at two and half years, provide evidence that nuclear transfer, despite multiple disorders, can result in physiologically normal, fertile animals.

Although some apparently normal cloned mice were produced, an aberrant expression pattern in NT embryos was observed even in these mice. This pattern concerned genes thought to be involved in stress adaptation, trophoblastic function, and DNA methylation during pre-implantation development. It has been shown that the culture of pre-implantation embryos affects the regulation of various imprinted and nonimprinted genes, leading to aberrant fetal growth and development [22-24].

No significant correlation between the anomalous fetal growth of cloned mice and abnormal expression of any single gene was seen [25]. The accumulated actions of abnormal gene expression at multiple loci ultimately
<table><caption>Table 1: The Postimplantation Development of Mouse-Cloned Embryos Derived from Different Cell Cycle Stages</caption><thead><tr><th rowspan="2">Donor cell cycle</th><th rowspan="2">No. of transferred</th><th rowspan="2">No. of implanted (%)</th><th colspan="3">No. of pups</th><th colspan="2">No. of survival after 1 week</th></tr><tr><th>Total</th><th>% from implanted</th><th>% from transferred</th><th>Total</th><th>% of born pups</th></tr></thead><tbody><tr><td>G2</td><td>276</td><td>63 (23)</td><td>5</td><td>10</td><td>2.2</td><td>2</td><td>40</td></tr><tr><td>G1</td><td>189</td><td>30(16)</td><td>3</td><td>10</td><td>1.6</td><td>1</td><td>33</td></tr><tr><td>M phase</td><td>1062</td><td>265(25)</td><td>21</td><td>7</td><td>2</td><td>8</td><td>38</td></tr></tbody></table>

resulted in embryonic or postnatal abnormalities. The high incidence of embryonic loss after implantation and postnatal death in clones suggests a need for characterizing molecular parameters that can be used to assess the developmental potential of pre-implantation embryos. Researchers are currently experimenting with different methods of identifying gene expression in nuclear transfer.

A cohort of such identified genes will provide a useful tool when analyzing the developmental potential of pre-implantation embryos. Another valued marker when assessing embryonic developmental potential is genomic methylation. Shi reported that aberrant methylation patterns at the two-cell stage zygote are an indicator of early developmental failure [26]. These authors have used an antibody to 5-methylcytosine to examine the immunostaining patterns of methylated genomic sites in two-cell zygotes developed from superovulated females, nonsuperovulated matings, and *in vitro* fertilization. A major conclusion of their work is that a methylcytosine staining pattern has been shown to be a valuable indicator of early developmental methylation reprogramming of the two parental genomes in normal or *in vitro* fertilized zygotes. The authors indicate that this immunostaining approach promises to be potentially useful for determining the safety and efficiency of technologies that assist with reproduction. To best explain aberrant reprogramming and the acquisition of apparently normal adult animals, there is an increasing need to explore how NT is affected by varying genetic backgrounds, the nuclear transfer procedure, and the synchronization of donors and recipients.

## Cell Cycle Coordination and NT Efficiency

Cell cycle synchronization has traditionally been thought the best way to improve the efficiencies of nuclear transfer. The benefit of using early-stage donor nuclei was confirmed by the enhanced rate of development of manipulated embryos to blastocysts with donor blastomeres in the early cell cycle stage (G1). Bypassing the S phase was also considered important for effective nuclear transfer [27,28].

After the delivery of the first cloned adult mammal, Dolly (which was produced by inducing donor nuclei into the quiescent state [4]), many living offspring were produced using quiescent, cultured donor cells [7,29–31]. It is generally believed that a diploid, G0/G1 stage of the cell cycle is required to initiate reprogramming following transfer of the donor nucleus into an inactivated, oocyte cytoplasm. This stage is also thought to ensure that the diploid of the cloned embryo is normal. Other groups have used cycling cells in presumptive G1 stage and have also obtained offspring [32]. As the majority of cumulus cells are presumed to be in the G0/G1 stage, they have also been used for donor cells [5].

We have found that the cell cycle stage of the donor cells could significantly interfere with *in vitro* development of stem cell generated NT embryos [33]. However, the implantation rate at day 7 is quite similar between the three types of nuclei (G2, 23%; G1, 16%; and M-phase, 25%). The pup delivery rates are also similar between metaphase and interphase groups at day 19 (M-phase, 2.0% vs. I-phase G1, 1.6% and G2, 1.9%). The survival rate of the cloned pups after one week is also similar between these two groups (M-phase, 38% vs. I-phase G1, 33% and G2, 40%). However, our results show that up to 85.1% of the cloned embryos develop to blastocysts when metaphase nuclei are injected, whereas this rate drops to about 20% when interphase nuclei are used (G1 and G2) (Table 1).

What does cell cycle synchronization alter? Evidence suggests that cell cycle synchronization can only change the rate of blastocyst formation. When we examined the chromatin remodeling of the injected nucleus during activation, we found that metaphase donor nuclei reformed a metaphase plate rapidly after transferring. Although 20% of the spindles were abnormal, with disordered chromosomal arrangement, 93.3% could form one pseudo pronucleus (PN) and one polar body (PB) 6 hrs after activation. Interphase nuclei underwent premature chromatin condensation (PCC), after which only 50% of the G1 formed 2 PN and 63% of the G2 formed one PN and one PB. In 20% of the cloned embryos derived from
interphase donor nuclei, fragment chromatin and condensed chromatin block were found.

MII cytoplasm is known to induce donor chromatin remodeling, a process that greatly depends upon the donor cell cycle stage. Our research shows that cell cycle synchronization changes the pattern of chromatin remodeling. By avoiding PCC, which may induce chromosomal abnormalities, metaphase donor cells are able to achieve a higher *in vitro* development rate. However, although pre-implantation development improved significantly in our research, post-implantation and full-term development were similar in every cell cycle stage analyzed. These data indicate that restoration of the nuclear totipotency depends more on the nature of the donor nucleus than its initial cell cycle stage.

## Embryonic and Adult Nuclei – Which Is Easier to Reprogram?

Before Dolly was born, only embryonic nuclei could be transferred and could reach full-term development; now, somatic nuclear transfer is a routine procedure. Various differentiated cell types have been used as sources of nuclei for cloning domestic and laboratory animals. Almost all cell types tested have resulted in live offspring, although with great differences in efficiency. Usually, the development of cloned embryos receiving a well-differentiated donor nuclei is less successful than for those transferred with low-differentiated donors. The survival until birth and adulthood of blastocysts that are derived from ES-cell, donor nuclei is much higher than for clones from somatic donor nuclei [34,35]. We have also found that ES cells seem to provide 20 times better development than cumulus cells [33,36]. Many developmentally important genes have also been detected in cloned embryos. Bortvin et al. [37] analyzed expression of *Oct4* and 10 *Oct4*-related genes in individual, cumulus, cell-derived, cloned blastocysts. They found that only 62% correctly expressed all tested genes. In contrast to this incomplete reactivation of *Oct4*-related genes in somatic clones, ES cell-derived, cloned blastocysts and normal control embryos expressed these genes normally. These authors postulated that clones derived from differentiated cell nuclei might fail to establish a population of truly pluripotent embryonic cells due to faulty reactivation of key embryonic genes.

It can be difficult to explain the development of cloned embryos solely by their differentiated states. Therefore, we tested ES cells and fibroblast cells with the same genotype (129/SvPas), synchronizing the donor nuclei from ES cells and somatic cells in metaphase. Pre-implantation and postimplantation development was checked at the blastocyst stage and at day 7.5 of pregnancy. We found that although there was an approximate 10-fold difference at the blastocyst stage between ES cells and fibroblast

cells, the implantation rate between the two groups was only an approximate two-fold difference. Surprisingly, the fetus rate (implantation with embryos from blastocyst transferring) at day 7.5 was three-fold lower (Table 2). The level of methylation is likely implicated in this result. ES cells have a high methylation activity compared to that of somatic cells [38]. To what extent the extensive demethylation of chromatin during pre-implantation development interferes with the remethylation of the genome during postimplantation stages remains to be determined.

<table><caption>**Table 2: Developmental Abilities of Embryos Reconstructed from ES cells and Somatic Cells with the Same Genetic Background (129/SvPas)**</caption><thead><tr><th rowspan="2"></th><th colspan="2">Development of cloned embryos at different stages (%)</th></tr><tr><th>ES cell</th><th>Fibroblast cell</th></tr></thead><tbody><tr><td>Blastocyst formation</td><td>50.0</td><td>6.0</td></tr><tr><td>Implantation</td><td>16.0</td><td>8.7</td></tr><tr><td>Fetus /embryo transferred</td><td>3.4</td><td>1.5</td></tr><tr><td>Fetus / implantation</td><td>29.0</td><td>17.1</td></tr><tr><td>Fetus / blastocyst</td><td>7.2</td><td>22.6</td></tr></tbody></table>

Similar epigenetic phenomena have also frequently been observed between subcultures (batches) derived from the same biopsy (thus from the same genotype and same differentiated state) for the bovine species [3] and for clonal cell lines of fibroblasts derived from the same pig fetus [39]. Daniels et al. [19,40] studied the expression of FGF4, FGFr2, and IL6 in the bovine nuclear transfer embryos reconstructed from granulosa and fetal epithelial cells. The authors detected aberrant expression of all three genes in bovine, granulosa, cell-derived, nuclear transfer embryos, but only the expression of FGF4 was observed to be aberrant in the fetal epithelial cell. Their results demonstrate the effects that different donor cell lines and different nuclear transfer procedures may have on the expression of developmentally important genes in nuclear transfer embryos.

In addition to epigenetic change, the nuclear transfer procedure and *in vitro* cultures of the reconstructed embryos also contribute to aberrant gene expression. Cox G.F. et al. [41] suggested that intracytoplasmic sperm injections might increase the risk of imprinting defects. Wrenzycki et al. [20] detected eight specific mRNAs in single blastocysts employing a semiquantitative, reverse transcription-polymerase chain-reaction assay using different nuclear transfer procedures. Their results showed that depending on the steps of the cloning procedure, nuclear transfer-derived embryos might display marked differences from their *in vitro*-produced, *in vivo*-derived counterparts.
## Future Prospects

Despite the increasing number of cloned animals produced, the nuclear transfer technique itself has changed little in the last ten years. Modification of the present procedure is required to improve efficiency. As a field, NT cloning must strive to better understand the mechanisms responsible for the currently variable somatic reprogramming to an embryonic or totipotent state. Through a systematic analysis of the molecular events controlling reprogramming of a donor genome will emerge highly efficient methods for NT cloning. Such advances will undoubtedly benefit the field of animal modeling using this technology.

## Acknowledgments

We are grateful to Dr. John F. Engelhardt for his suggestions and comments on the manuscript.

## References

1. Dinnyes A, De Sousa P, King T and Wilmut I: **Somatic cell nuclear transfer: recent progress and challenges.** *Cloning Stem Cells* 2002, 4:81-90.

2. Renard JP, Zhou Q, Le Bourhis D, Chavatte-Palmer P, Hue I, Heyman Y and Vignon X: **Nuclear transfer technologies: between successes and doubts.** *Theriogenology* 2002, 57:203-222.

3. Heyman Y, Zhou Q, Lebourhis D, Chavatte-Palmer P, Renard JP and Vignon X: **Novel approaches and hurdles to somatic cloning in cattle.** *Cloning Stem Cells* 2002, 4:47-55.

4. Wilmut I, Schnieke AE, McWhir J, Kind AJ and Campbell KH: **Viable offspring derived from fetal and adult mammalian cells.** *Nature* 1997, 385:810-813.

5. Wakayama T, Perry AC, Zuccotti M, Johnson KR and Yanagimachi R: **Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei.** *Nature* 1998, 394:369-374.

6. Galli C, Duchi R, Moor RM and Lazzari G: **Mammalian leukocytes contain all the genetic information necessary for the development of a new individual.** *Cloning* 1999, 1:161-170.

7. Baguisi A, Behboodi E, Melican DT, Pollock JS, Destrempes MM, Cammuso C, Williams JL, Nims SD, Porter CA and Midura P et al.: **Production of goats by somatic cell nuclear transfer.** *Nat Biotechnol* 1999, 17:456-461.

8. Polejaeva IA, Chen SH, Vaught TD, Page RL, Mullins J, Ball S, Dai Y, Boone J, Walker S and Ayares DL et al.: **Cloned pigs produced by nuclear transfer from adult somatic cells.** *Nature* 2000, 407:86-90.

9. Chesne P, Adenot PG, Viglietta C, Baratte M, Boulanger L and Renard JP: **Cloned rabbits produced by nuclear transfer from adult somatic cells.** *Nat Biotechnol* 2002, 20:366-369.

10. Shin T, Kraemer D, Pryor J, Liu L, Rugila J, Howe L, Buck S, Murphy K, Lyons L and Westhusin M: **A cat cloned by nuclear transplantation.** *Nature* 2002, 415:859.

11. Woods GL, White KL, Vanderwall DK, Li GP, Aston KI, Bunch TD, Meerdo LN and Pate BJ: **A Mule Cloned from Fetal Cells by Nuclear Transfer.** *Science* 2003. [epub before print]

12. Galli C, Lagutina I, Crotti G, Colleoni S, Turini P, Ponderato N, Duchi R and Lazzari G: **a cloned horse born to its dam twin.** *Nature* 2003, 424:635.

13. Zhou Q, Renard JP, Le Friec G, Brochard V, Beaujean N, Cherifi Y, Fraichard A and Cozzi J: **Generation of Fertile Cloned Rats by Regulating Oocyte Activation.** *Science* 2003 in press.

14. Tamashiro KL, Wakayama T, Akutsu H, Yamazaki Y, Lachey JL, Wortman MD, Seeley RJ, D'Alessio DA, Woods SC and Yanagimachi R et al.: **Cloned mice have an obese phenotype not transmitted to their offspring.** *Nat Med* 2002, 8:262-267.

15. Ogonuki N, Inoue K, Yamamoto Y, Noguchi Y, Tanemura K, Suzuki O, Nakayama H, Doi K, Ohtomo Y and Satoh M et al.: **Early death of mice cloned from somatic cells.** *Nat Genet* 2002, 30:253-254.

16. Schnieke AE, Kind AJ, Ritchie WA, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A and Campbell KH: **Human factor IX trans-

genic sheep produced by transfer of nuclei from transfected fetal fibroblasts. *Science* 1997, 278:2130-2133.

17. Vignon X, Chesne P, Le Bourhis D, Flechon JE, Heyman Y and Renard JP: **Developmental potential of bovine embryos reconstructed from enucleated mature oocytes fused with cultured somatic cells.** *C R Acad Sci III* 1998, 321:735-45.

18. Hill JR, Roussel AJ, Cibelli JB, Edwards JF, Hooper NL and Miller MW: **Clinical and pathologic features of cloned transgenic calves and fetuses (13 case studies).** *Theriogenology* 1999, 51:1451-1465.

19. Daniels R, Hall VJ, French AJ, Korfiatis NA and Trounson AO: **Comparison of gene transcription in cloned bovine embryos produced by different nuclear transfer techniques.** *Mol Reprod Dev* 2001, 60:281-288.

20. Wrenzycki C, Wells D, Herrmann D, Miller A, Oliver J, Tervit R and Niemann H: **Nuclear transfer protocol affects messenger RNA expression patterns in cloned bovine blastocysts.** *Biol Reprod* 2001, 65:309-317.

21. Humpherys D, Eggan K, Akutsu H, Friedman A, Hochedlinger K, Yanagimachi R, Lander ES, Golub TR and Jaenisch R: **Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei.** *Proc Natl Acad Sci U S A* 2002, 99:12889-12894.

22. Feil R: **Early-embryonic culture and manipulation could affect genomic imprinting.** *Trends Mol Med* 2001, 7:245-246.

23. Khosla S, Dean W, Brown D and Reik R: **Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes.** *Biol Reprod* 2001, 64:918-926.

24. Natale D, DeSousa PA, Westhusin ME and Watson A: **Sensitivity of bovine blastocyst gene expression patterns to culture environments assessed by differential display RT-PCR.** *Reproducion* 2001, 122:687-693.

25. Humpherys D, Eggan K, Akitsu H, Hochedlinger K, Rideout WM, Biniszkiewicz D, Yanagimachi R and Jaenisch R: **Epigenetic instability in ES cells and cloned mice.** *Science* 2001, 293:95-97.

26. Shi W and Haaf T: **Aberrant methylation patterns at the two-cell stages as an indicator of early developmental failure.** *Mol Reprod Dev* 2002, 63:329-334.

27. Collas P, Pinto-Correia C, Ponce de Leon FA and Robl JM: **Effect of donor cell cycle stage on chromatin and spindle morphology in nuclear transplant rabbit embryos.** *Biol Reprod* 1992, 46:501-11.

28. Collas P, Balise JJ and Robl JM: **Influence of cell cycle stage of the donor nucleus on development of nuclear transplant rabbit embryos.** *Biol Reprod* 1992, 46:492-500.

29. Kato Y, Tani T, Sotomaru Y, Kurokawa K, Kato J, Doguchi H, Yasue H and Tsunoda Y: **Eight calves cloned from somatic cells of a single adult.** *Science* 1998, 282:2095-2098.

30. Kasinathan P, Knott JG, Wang Z, Jerry DJ and Robl JM: **Production of calves from G1 fibroblasts.** *Nat Biotechnol* 2001, 19:1176-1178.

31. Wells DN, Laible G, Tucker FC, Miller AL, Oliver JE, Xiang T, Forsyth JT, Berg MC, Cockrem K and L'Huillier PJ et al.: **Coordination between donor cell type and cell cycle stage improves nuclear cloning efficiency in cattle.** *Theriogenology* 2003, 59:45-59.

32. Cibelli JB, Stice SL, Golueke PJ, Kane JJ, Jerry J, Blackwell C, Ponce de Leon FA and Robl JM: **Cloned transgenic calves produced from nonquiescent fetal fibroblasts.** *Science* 1998, 280:1256-1258.

33. Zhou Q, Jouneau A, Brochard V, Adenot P and Renard JP: **Developmental potential of mouse embryos reconstructed from metaphase embryonic stem cell nuclei.** *Biol Reprod* 2001, 65:412-419.

34. Rideout WM, Wakayama T, Wutz A, Eggan K, Jackson-Grusby L, Dausman J, Yanagimachi R and Jaenisch R: **Generation of mice from wild-type and targeted ES cells by nuclear cloning.** *Nat Genet* 2000, 24:109-110.

35. Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM, Yanagimachi R and Jaenisch R: **Hybrid vigor fetal overgrowth and viability of mice derived by nuclear cloning and tetraploid embryo complementation.** *Proc Natl Acad Sci U S A* 2001, 98:6209-6214.

36. Zhou Q, Boulanger L and Renard JP: **A simplified method for the reconstruction of fully competent mouse zygotes from adult somatic donor nuclei.** *Cloning* 2000, 2:35-44.

37. Bortvin A, Eggan K, Skaletsky H, Akutsu H, Berry DL, Yanagimachi R, Page DC and Jaenisch R: **Incomplete reactivation of Oct4-
related genes in mouse embryos cloned from somatic nuclei.
*Development* 2003, **130**:1673-1680.

38. Lei H, Oh SP, Okano M, Juttermann R, Goss KA, Jaenisch R and Li E: **De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.** *Development* 1996, **122**:3195-3205.

39. Ktihholzer B, Hawley RJ, Lai L, Kolber-Simonds D and Prather RS: **Clonal lines of transgenic fibroblast cells derived from the same fetus result in different development when used for nuclear transfer in pigs.** *Biol Reprod* 2001, **64**:1695-1698.

40. Daniels R, Hall V and Trounson AO: **Analysis of gene transcription in bovine nuclear transfer embryos reconstructed with granulosa cell nuclei.** *Biol Reprod* 2000, **63**:1034-1040.

41. Cox GF, Burger J, Lip V, Mau UA, Sperling K, Wu BL and Horsthemke B: **Intracytoplasmic sperm injection may increase the risk of imprinting defects.** *Am J Hum Genet* 2002, **71**:162-164.

Publish with **BioMed Central** and every
scientist can read your work free of charge

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime."

Sir Paul Nurse, Cancer Research UK

Your research papers will be:

* available free of charge to the entire biomedical community

* peer reviewed and published immediately upon acceptance

* cited in PubMed and archived on PubMed Central

* yours — you keep the copyright

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

<figure><img src="image_2.png" /></figure>

BioMedcentral